Literature DB >> 14511247

BHIVA Guidelines: coinfection with HIV and chronic hepatitis B virus.

M G Brook1, R Gilson, E L Wilkins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14511247     DOI: 10.1046/j.1468-1293.4.s1.1.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


× No keyword cloud information.
  5 in total

1.  A case for treating high hepatitis B DNA levels before starting HIV therapy.

Authors:  Jason V Baker; David R Boulware; Paul R Bohjanen
Journal:  AIDS       Date:  2006-11-28       Impact factor: 4.177

2.  Current therapy for hepatitis C or D or immunodeficiency virus concurrent infection with chronic hepatitis B.

Authors:  Rong-Nan Chien
Journal:  Hepatol Int       Date:  2008-04-10       Impact factor: 6.047

Review 3.  Management of hepatitis B in patients coinfected with the human immunodeficiency virus.

Authors:  R Lessells; C Leen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-04-27       Impact factor: 3.267

4.  Causes of Death among AIDS Patients after Introduction of Free Combination Antiretroviral Therapy (cART) in Three Chinese Provinces, 2010-2011.

Authors:  Liyan Wang; Lin Ge; Lu Wang; Jamie P Morano; Wei Guo; Kaveh Khoshnood; Qianqian Qin; Zhengwei Ding; Dingyong Sun; Xiaoyan Liu; Hongbing Luo; Jonas Tillman; Yan Cui
Journal:  PLoS One       Date:  2015-10-27       Impact factor: 3.240

5.  Liver Fibrosis Regression Measured by Transient Elastography in Human Immunodeficiency Virus (HIV)-Hepatitis B Virus (HBV)-Coinfected Individuals on Long-Term HBV-Active Combination Antiretroviral Therapy.

Authors:  Jennifer Audsley; Christopher Robson; Stacey Aitchison; Gail V Matthews; David Iser; Joe Sasadeusz; Sharon R Lewin
Journal:  Open Forum Infect Dis       Date:  2016-02-12       Impact factor: 3.835

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.